Compared with control HCC-Mock’-Co cells, HCC-shTGM2-Co cells exhibited less invasion and resistance to cisplatin in association with increased E-cadherin expression and reduced vimentin expression (Fig. 4a–c). This evidence concerns the gene CDH1 and hepatocellular carcinoma.